CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 34 filers reported holding CHAMPIONS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,159 | -26.2% | 33,466 | -25.3% | 0.00% | – |
| Q2 2023 | $281,981 | +116421.1% | 44,830 | -25.6% | 0.00% | – |
| Q1 2023 | $242 | -9.4% | 60,253 | +1.8% | 0.00% | – |
| Q4 2022 | $267 | -99.9% | 59,202 | +8.8% | 0.00% | – |
| Q3 2022 | $408,000 | -4.0% | 54,422 | +3.6% | 0.00% | – |
| Q2 2022 | $425,000 | -2.7% | 52,548 | -2.3% | 0.00% | – |
| Q1 2022 | $437,000 | +0.9% | 53,801 | -0.7% | 0.00% | – |
| Q4 2021 | $433,000 | -29.8% | 54,186 | -10.3% | 0.00% | – |
| Q3 2021 | $617,000 | -32.0% | 60,411 | -31.6% | 0.00% | -100.0% |
| Q2 2021 | $908,000 | +521.9% | 88,310 | +493.9% | 0.00% | – |
| Q1 2019 | $146,000 | +22.7% | 14,869 | -2.2% | 0.00% | – |
| Q4 2018 | $119,000 | -73.1% | 15,196 | -40.1% | 0.00% | -100.0% |
| Q3 2018 | $443,000 | +705.5% | 25,369 | +79.1% | 0.00% | – |
| Q4 2017 | $55,000 | -32.1% | 14,164 | -35.7% | 0.00% | – |
| Q3 2017 | $81,000 | +118.9% | 22,017 | -1.3% | 0.00% | – |
| Q3 2016 | $37,000 | – | 22,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Battery Partners IX, LLC | 1,953,549 | $7,111,000 | 7.42% |
| NEA Management Company, LLC | 1,562,500 | $5,688,000 | 0.25% |
| SHEPHERD KAPLAN KROCHUK, LLC | 21,564 | $78,000 | 0.05% |
| Perceptive Advisors | 366,973 | $1,335,000 | 0.04% |
| Granite Investment Partners, LLC | 139,698 | $509,000 | 0.03% |
| Sandy Spring Bank | 8,333 | $30,000 | 0.00% |
| Veritas Investment Management (UK) Ltd | 2,083 | $8,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,753 | $6,000 | 0.00% |
| VANGUARD GROUP INC | 152,722 | $553,000 | 0.00% |
| MORGAN STANLEY | 3,500 | $13,000 | 0.00% |